Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferences

Information for Patients

View all Images (30)

Cutaneous T-cell lymphoma in Child
See also in: Nail and Distal Digit
Other Resources UpToDate PubMed

Cutaneous T-cell lymphoma in Child

See also in: Nail and Distal Digit
Contributors: Vivian Wong MD, PhD, Belinda Tan MD, PhD, Art Papier MD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Primary cutaneous lymphomas may be either of T- or B-cell origin. Cutaneous T-cell lymphomas (CTCLs) account for 75%-80% of these lymphomas and are a heterogeneous group of neoplasms that vary considerably in their clinical presentation, histology, immunophenotype, genetics, and prognosis. CTCLs are seen most often in the elderly, but they can occur in patients of all ages. CTCL in children is rare, accounting for roughly 5% of all cases. It has been reported to occur as early as the second year of life. Most children with mycosis fungoides show good response to treatment, with at least partial clearing within a year; progression to more advanced disease within this time frame has been noted to be rare. However, longer-term studies are lacking and so overall prognosis is uncertain.

The definitive diagnosis of CTCL may require large or multiple biopsies as well as specialized testing of the biopsy specimens. Typing of the CTCL and staging are important to determine the extent of disease and treatment strategy.

Mycosis fungoides and its variants (folliculotropic mycosis fungoides, pagetoid reticulosis, and granulomatous slack skin), Sézary syndrome, lymphomatoid papulosis, and cutaneous anaplastic large cell lymphoma make up 90% of all CTCL cases.

This summary focuses on mycosis fungoides and variants and Sézary syndrome.

Other types of CTCL discussed separately include subcutaneous panniculitis-like T-cell lymphoma, adult T-cell leukemia / lymphoma, and nasal type extranodal NK/T-cell lymphoma.
 
Mycosis Fungoides
Mycosis fungoides (MF) is the most common type of CTCL, accounting for 50% of all primary CTCL cases. Erythematous patches and plaques with fine scale and tumors that anatomically favor the buttocks and sun-protected areas of the trunk and limbs characterize this subtype. The etiology remains unclear. Current hypotheses propose that persistent antigenic stimulation occurs and that CD8+ T-cells play a critical role. MF takes on an indolent course over years to decades. Associated features include pruritus, poikiloderma in the patch stage, and ulceration of tumors. Poikilodermatous MF, a variant of patch stage MF, was seen in a higher percentage of children than has been reported in adults in one study. Extracutaneous involvement correlates with generalized skin involvement and erythroderma. Neoplastic T-cells demonstrate a memory T-cell phenotype: CD3+, CD4+, CD45RO+. MF staging requires CTCL physician specialists. Some consider large plaque parapsoriasis to be early patch stage MF.

Hypopigmented MF – A hypopigmented variant of MF is seen primarily in individuals of African descent but has also been reported in those of Asian, Indian, and Latin American descent. The hypopigmented variant is the most common form seen in childhood, accounting for over half of cases. The average age of diagnosis is 17 years.

Folliculotropic MF – This is characterized by lesions on the head and neck clinically and follicular involvement ("folliculotropism") microscopically. Most cases are seen in adult males, but children and adolescents may also be affected. It is the second most common variant in childhood. Early stage (IA, IB) disease with patches and plaques with follicular accentuation and keratosis pilaris-like or acneiform lesions may exhibit better prognosis with an indolent course. These lesions have a predilection for the trunk and extremities. On the other hand, advanced stage (IIB) disease with indurated or infiltrative alopecic plaques and tumors may be more aggressive with poorer prognosis. These lesions favor the head and neck and are more pruritic. 5-year survival rate approaches 80%.

Pagetoid reticulosis – Pagetoid reticulosis, also known as Woringer-Kolopp disease, is rarely reported in childhood. It represents approximately 1% of all cases of CTCL. It is a localized variant of MF, characterized by a solitary, slow-growing patch or plaque on a distal extremity clinically and striking epidermotropism microscopically. Pagetoid reticulosis has a predilection for middle-aged males but it can be seen in any age group. Prognosis is excellent with a 100% 5-year survival rate.

Ketron-Goodman disease is a disseminated and aggressive variant of pagetoid reticulosis with a potential for systemic involvement.

Granulomatous slack skin – Granulomatous slack skin, also known as granulomatous dermohypodermitis, is a rare variant of CTCL (<1% of all cases) that is very rarely seen in childhood. It is characterized by asymptomatic pendulous loose skin masses in the body folds clinically, and granulomatous T-cell infiltration microscopically. The disease may be associated with a lymphoproliferative disorder, such as MF, Hodgkin lymphoma, and non-Hodgkin lymphoma. Males in the third and fourth decades are more commonly affected. Overall, prognosis is good with a 100% 5-year survival rate.

Sézary Syndrome
While erythrodermic MF has been reported in childhood, true Sézary syndrome has not.

Codes

ICD10CM:
C84.A0 – Cutaneous T-cell lymphoma, unspecified, unspecified site

SNOMEDCT:
400122007 – Primary cutaneous T-cell lymphoma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Hypopigmented variant of MF (common in children):
Patch and plaque stage MF:
  • Atopic dermatitis – Common in childhood, and CTCL can present with thin, scaly plaques as does atopic dermatitis. Mild to moderate spongiosis is seen on histology. Look for lichenified plaques on the flexural surfaces and neck.
  • Superficial fungal infections (eg, tinea corporis) – Erythematous plaques with a raised, red scaling border. Central clearing is more common in tinea corporis. Check KOH.
  • Seborrheic dermatitis – Sebaceous distribution of erythematous scaling plaques. Chronic history of mesiolabial, glabellar, auricular pruritus, erythema, scale.
  • Chronic contact dermatitis (allergic, irritant) – Bright red erythematous or vesiculating plaques.
  • Psoriasis – Look for erythematous silver-scaled plaques, nail oil-drop changes, and nail pitting. A family history of psoriasis is often noted. Psoriasis and CTCL are histologically different, and a biopsy will aid in the diagnosis.
  • Childhood pityriasis rubra pilaris (PRP) – Look for orange-red, waxy-like keratoderma of the palms and soles. Islands of normal skin within larger plaques are characteristically seen in PRP. PRP and CTCL are histologically different, and a biopsy will aid in the diagnosis.
  • Pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica – While both may display a clonal population of T cells, these are benign disorders.
  • Pityriasis rosea
  • Lichen planus
Tumor stage:
Folliculotropic MF:
Pagetoid reticulosis:
Granulomatous slack skin:

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Updated:06/07/2021
Copyright © 2023 VisualDx®. All rights reserved.
Patient Information for Cutaneous T-cell lymphoma in Child
Print E-Mail Images (30)
Contributors: Nicole C. Syder, Cheri Frey MD

Overview

Cutaneous T-cell lymphoma is a type of cancer that starts in blood cells in the skin called T-cells. The most common type of cutaneous T-cell lymphoma is mycosis fungoides.

Individuals with mycosis fungoides may have a rash that is similar to eczema, psoriasis, lichen planus, and other skin conditions. In darker skin colors, the rash may appear maroon, purple, dark brown, or grayish, whereas in lighter skin colors, the rash typically appears faint pink, light brown, or light red. 

Mycosis fungoides tends to be chronic and recurring, meaning people with this disease often need multiple treatments for their rash to go away and to prevent the disease from getting worse. Usually, mycosis fungoides is limited to a patchy rash on the skin. In a small set of people, mycosis fungoides progresses to involve their entire skin surface, lymph nodes, and internal organs.

The exact cause of mycosis fungoides is unknown, but research has shown links to a group of viruses called retroviruses (for example, human T-lymphotropic virus type 1 [HTLV-1]) and to cancer-causing substances.

Who’s At Risk

Mycosis fungoides most commonly occurs in older adults, with the usual age at diagnosis being in the mid-50s. The number of people affected by mycosis fungoides significantly increases with age.

Mycosis fungoides affects men twice as often as women. It is more common in and is also more aggressive in Black individuals, especially Black women who develop the disease early in life.

Signs & Symptoms

The classic appearance of mycosis fungoides includes red or brown, scaly or wrinkled, raised patches (areas larger than a thumbnail) of varying thickness. The buttocks and behind the underarms are areas that are typically affected, but mycosis fungoides can occur on other areas of the skin as well. Mycosis fungoides patches are generally 5 cm or larger. Sometimes, a full-body rash develops.
Raised, smooth nodules (bumps that are firm to the touch) can be seen on the skin.

There may also be skin that is lighter than the surrounding skin (hypopigmented) or darker than the surrounding skin (hyperpigmented).

Mycosis fungoides is not usually itchy or painful.

A fullness in the underarms or groin area may mean the lymph nodes are affected.

Self-Care Guidelines

Mycosis fungoides cannot be managed with over-the-counter treatment, so it is important to see a medical professional.

When to Seek Medical Care

  • Seek medical advice if you develop unexplained lightening or darkening of the skin or a new or unexplained rash.
  • Although the buttocks, breasts, and skin folds are the most commonly affected areas, rashes in other areas of the body should not be ignored.

Treatments

  • If your dermatologist or other medical professional suspects mycosis fungoides, they will likely perform one or more skin biopsies and may perform bloodwork.
  • For mycosis fungoides affecting the skin only, your dermatologist or other medical professional may prescribe topical corticosteroid creams, other topical therapies, light treatment (phototherapy), or oral medications (such as acitretin [Soriatane], bexarotene [Targretin], or methotrexate [Xatmep]).
  • For mycosis fungoides affecting large areas of the skin, lymph nodes, and/or internal organs, your medical professional may also recommend injectable therapies, electron beam therapy, extracorporeal photopheresis, or chemotherapy.
Copyright © 2023 VisualDx®. All rights reserved.
Cutaneous T-cell lymphoma in Child
See also in: Nail and Distal Digit
A medical illustration showing key findings of Cutaneous T-cell lymphoma (Mycosis Fungoides) : Hyperpigmented patch, Lymphadenopathy, Tumor, Pruritus
Clinical image of Cutaneous T-cell lymphoma - imageId=70243. Click to open in gallery.  caption: 'Patch stage mycosis fungoides, showing thin scaly erythematous and brown plaques on the lower abdomen.'
Patch stage mycosis fungoides, showing thin scaly erythematous and brown plaques on the lower abdomen.
Copyright © 2023 VisualDx®. All rights reserved.